Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Be Wary of Lordstown Motors’ Awkward Dancing Partner

By Josh Enomoto, InvestorPlace Contributor

With a Joe Biden win, RIDE stock seems destined to climb. However, shares have an uncomfortable correlation with a controversial EV firm.

How the Risk in Workhorse May Have Entered the Left Lane

By Josh Enomoto, InvestorPlace Contributor

Thanks to increased demand for contactless delivery, the case for WKHS stock improved dramatically. Still, it doesn’t hurt to be careful -- not everything about this story is positive.

Good News for Society Isn’t Necessarily So for Slack Stock

By Josh Enomoto, InvestorPlace Contributor

One of the conspicuous coronavirus plays, Slack stock may face some turbulence as some viable vaccines may be on the horizon.

Could a ‘Green Wave’ Finally Lift Aphria Out of Its Funk?

By Josh Enomoto, InvestorPlace Contributor

With increasing demand for cannabis-based products and an impactful transition of power, APHA stock may be worth a shot.

7 Biotech Penny Stocks Worth a Gamble

By Josh Enomoto, InvestorPlace Contributor

With the pandemic drawing much attention toward biotech stocks, there are some interesting ideas among in the small-cap field, but only if you understand the severe risks involved.

Load More